Literature DB >> 10626925

Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression.

C M Leung1, Y K Wing, P K Kwong, A Lo, K Shum.   

Abstract

OBJECTIVE: The aim of this study was to validate the Chinese-Cantonese version of the Hospital Anxiety and Depression Scale (HADS) and to compare it with the Hamilton Rating Scale of Depression (HRSD) as a screening tool for depressive disorders in general hospital in-patients.
METHOD: The Chinese-Cantonese version of the HADS was administered to general hospital in-patients seen on a consultation basis, and psychiatric diagnoses were made according to DSM-III-R. The subjects were further rated independently with the HRSD.
RESULTS: The Chinese-Cantonese version of the HADS was found to have good internal consistency and external validity, with favourable sensitivity and specificity for screening for psychiatric disorders. However, its performance was marginally inferior to that of the HRSD. The scale also performed poorly in identifying major depression.
CONCLUSION: The HADS has limitations with regard to identification of depressive disorders. However, despite its shortcomings, it remains one of the best paper-and-pencil tests for screening psychiatric disorders in the medically ill.

Entities:  

Mesh:

Year:  1999        PMID: 10626925     DOI: 10.1111/j.1600-0447.1999.tb10897.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  78 in total

1.  Long-term fatigue state in postoperative patients with breast cancer.

Authors:  Xiao-Fang Tan; Fang Xia
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

2.  The "self" in pain: the role of psychological inflexibility in chronic pain adjustment.

Authors:  Silvia Sze Wai Kwok; Esther Chin Chi Chan; Phoon Ping Chen; Barbara Chuen Yee Lo
Journal:  J Behav Med       Date:  2016-06-08

3.  Benefit finding predicts depressive and anxious symptoms in women with breast cancer.

Authors:  Yuping Wang; Xiongzhao Zhu; Jinyao Yi; Lili Tang; Jincai He; Gannong Chen; Lingyan Li; Yuling Yang
Journal:  Qual Life Res       Date:  2015-05-24       Impact factor: 4.147

Review 4.  Psychological interventions for acute pain after open heart surgery.

Authors:  Susanne Ziehm; Jenny Rosendahl; Jürgen Barth; Bernhard M Strauss; Anja Mehnert; Susan Koranyi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

5.  Validation of Chinese and English versions of the Holistic Well-being Scale in patients with cancer.

Authors:  Geok Ling Lee; Gilbert Kam Tong Fan; Sally Wai Chi Chan
Journal:  Support Care Cancer       Date:  2015-04-17       Impact factor: 3.603

6.  Validation of the chronic heart failure questionnaire (Chinese version).

Authors:  Diana T F Lee; Doris S F Yu; Jean Woo
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

7.  Validation of the Chinese version of Underwood's Daily Spiritual Experience Scale--transcending cultural boundaries?

Authors:  Siu-Man Ng; Ted C T Fong; Elaine Y L Tsui; Friendly S W Au-Yeung; Sally K W Law
Journal:  Int J Behav Med       Date:  2009-03-17

8.  Psychometric evaluation of the Hospital Anxiety and Depression Scale in a large community sample of adolescents in Hong Kong.

Authors:  Ya-Fen Chan; Doris Y P Leung; Daniel Y T Fong; Chi-Ming Leung; Antoinette M Lee
Journal:  Qual Life Res       Date:  2010-04-07       Impact factor: 4.147

9.  Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression.

Authors:  Yuqi Zhang; Changsong Zhang; Guozhen Yuan; Jianjun Yao; Zaohuo Cheng; Chaojun Liu; Qinghai Liu; Gairong Wan; Guizhi Shi; Yiren Cheng; Yang Ling; Ke Li
Journal:  Behav Brain Funct       Date:  2010-08-25       Impact factor: 3.759

10.  Examining item bias in the anxiety subscale of the Hospital Anxiety and Depression Scale in patients with chronic obstructive pulmonary disease.

Authors:  Wai-Kwong Tang; Eric Wong; Helen F K Chiu; C M Lum; Gabor S Ungvari
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.